Academia-2-Entrepreneurs Videoportal

The “Academia-2-Entrepreneurs (A2E)” project simplifies the early engagement with the challenges and opportunities of founding a company in the health sector. The series of video interviews with established founders, provides students and young researchers from health sciences and medicine with valuable insights into important first steps as an entrepreneur in Austria. It serves as inspiration for those considering a career in the start-up world.

Discover the exciting insights of start-up founders in Austria by clicking on the videos below!

Do you want to learn more? Discover our Insights Report, learn about the project funder and partners or visit our project website here.

Do prefer to see this website in German? Besuchen Sie die deutschsprachige Version dieser Webseite hier.

Ablevia

Meet Oskar Smrzka, Founder and CEO/CSO of Ablevia. Ablevia was at the Vienna BioCenter Campus in 2018 and was as born from the idea that deep knowledge about the target structures of antibodies should enable to create a therpautic principle for the rapid removal of harmful and disease-causing antibodies.

www.ablevia.com

Meet Oskar Smrzka, Founder and CEO/CSO of Ablevia. Ablevia was at the Vienna BioCenter Campus in 2018 and was as born from the idea that deep knowledge about the target structures of antibodies should enable to create a therpautic principle for the rapid removal of harmful and disease-causing antibodies.

www.ablevia.com

BiomeDx

Meet Barbara Sladek, founder and CEO of BiomeDx. Her startup was founded with the aim of uncovering the secrets of the human gut microbiome and establishing diagnostics. To this end, BiomeDx has developed a microbiome analysis platform to analyse human stool samples using DNA sequencing and subsequent bioinformatic algorithms.

www.biome-dx.com

Meet Barbara Sladek, founder and CEO of BiomeDx. Her startup was founded with the aim of uncovering the secrets of the human gut microbiome and establishing diagnostics. To this end, BiomeDx has developed a microbiome analysis platform to analyse human stool samples using DNA sequencing and subsequent bioinformatic algorithms.

www.biome-dx.com

Brightmind.AI

Meet Tamara Gerbert, Co-Founder and CEO of Brightmind.AI. Her company brings clinically proven, self-learning brainstimulation to everyday life. Starting by addressing a literal pain point, migraines, Brightmind.AI’s neuromodulation approach has been shown to be dramatically more effective than currently available solutions, without the side effects of pharmaceuticals.

www.brightmind.ai

Meet Tamara Gerbert, Co-Founder and CEO of Brightmind.AI. Her company brings clinically proven, self-learning brainstimulation to everyday life. Starting by addressing a literal pain point, migraines, Brightmind.AI’s neuromodulation approach has been shown to be dramatically more effective than currently available solutions, without the side effects of pharmaceuticals.

www.brightmind.ai

Lumetry Diagnostics

Meet Antonia Riva-Frizberg, Co-Founder and Co-CEO of Lumetry Diagnostics. The Graz-based start-up specialises in R&D of respiratory monitoring systems for patients with lung disease. The company’s vision is to help people gain better control over their lung disease from the comfort of their own home, thereby improving their quality of life.

www.lumetry-diagnostics.com

Meet Antonia Riva-Frizberg, Co-Founder and Co-CEO of Lumetry Diagnostics. The Graz-based start-up specialises in R&D of respiratory monitoring systems for patients with lung disease. The company’s vision is to help people gain better control over their lung disease from the comfort of their own home, thereby improving their quality of life.

www.lumetry-diagnostics.com

Neurolentech

Meet Carsten Pfeffer, Co-founder and CSO/CTO of Neurolentech. The start-up was founded in late 2020 as a spin-out from IST Austria to identify new treatments for neurodevelopmental diseases. They use the latest scientific laboratory techniques to develop patient-derived neuronal cell models that give us insights into the molecular mechanisms of disease and are used to develop new potential treatments.

www.neurolentech.com

Meet Carsten Pfeffer, Co-founder and CSO/CTO of Neurolentech. The start-up was founded in late 2020 as a spin-out from IST Austria to identify new treatments for neurodevelopmental diseases. They use the latest scientific laboratory techniques to develop patient-derived neuronal cell models that give us insights into the molecular mechanisms of disease and are used to develop new potential treatments.

www.neurolentech.com

Somareality

Meet Adrian Brodesser, Founder and Co-CEO of Somareality. His start-up develops scientifically validated digital biomarkers based on eye tracking and helps their customers build products utilising this technology. The software is used in particular by customers in the aviation and health sectors to optimise training and therapy processes.

www.somareality.com

Meet Adrian Brodesser, Founder and Co-CEO of Somareality. His start-up develops scientifically validated digital biomarkers based on eye tracking and helps their customers build products utilising this technology. The software is used in particular by customers in the aviation and health sectors to optimise training and therapy processes.

www.somareality.com

Sqail

Meet Christian Bouda, founder and CEO of Sqail. His start-up that is dedicated to developing a revolutionary medical device for individuals with diabetes who suffer from neuropathy. This device is designed to alleviate the debilitating pain associated with the condition, enabling patients to lead a pain-free life once again.

www.sqail.com

Meet Christian Bouda, founder and CEO of Sqail. His start-up that is dedicated to developing a revolutionary medical device for individuals with diabetes who suffer from neuropathy. This device is designed to alleviate the debilitating pain associated with the condition, enabling patients to lead a pain-free life once again.

www.sqail.com

Insights Report

The Funder and Project Partners